Just reading the annual report and here is one relevant quote:
"Discussions with prospective partners span ArTiMist™, the other
clinical-stage oral sprays, as well as the application of SUDA’s
OroMist drug delivery technology to new drugs. Discussions are
at various stages with some companies having completed due
diligence and initiated deal negotiations."
Just reading the annual report and here is one relevant quote:...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.015(10.7%) |
Mkt cap ! $162.9M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.5¢ | 14.0¢ | $348.8K | 2.410M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33333 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 161915 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |